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The concept of comorbidity in somatoform disorder—a
DSM-V alternative for the DSM-IV classification of
Somatoform disorder☆
Dear Editor:
Somatoform disorders, first introduced as such in DSM-
III, are a controversial category, and the concept of
comorbidity seems to play an essential role in this
controversy [1–3]. Presentation of depressive disorder or
other psychological distress by medical symptoms is
common in many cultures [4] as established in research in
several countries and health care settings, and it has been
established that depressed patients indeed do not feel well
physically. This somatic presentation negatively influences
recognition of the depressive disorder or other mental
disorder by the general practitioner, which results in
undertreatment of a majority of patients. Although comor-
bidity between somatoform disorders, mood disorders, and
anxiety disorders is high [2,5,6], it is not handled as an
uniform criterion in the heterogeneous set of somatoform
disorders assembled as such in the DSM-IV. In some
somatoform disorders, including pain disorder, hypochon-
driasis, body dysmorphic disorder, and the undifferentiated
type, DSM-IV specifies the presence of a comorbid mental
disorder as an exclusion criterion. In contrast, it does not do
so for conversion disorder, somatization disorder, or somato-
form disorder not otherwise specified. Furthermore, the
exclusion criterion that is specified—that the symptoms are
not better accounted for by the comorbidity than by the
somatoform disorder itself—is difficult to apply in clinical
practice. The question has been raised if not comorbidity, but
co-syndromality is the case for depressive, anxiety, and
somatoform disorder. Cosyndromality is the phenomenon
that a symptom spectrum has physical as well as psycholo-
gical symptoms that are classified in different syndromes that
are nevertheless of similar kin [7]. An increasing literature on
the Diagnostic Criteria for Psychosomatic Research (DCPR)
has attempted to better capture the essential diagnostic issues
in such patients, which can be useful in cases where anxiety
and depression do not account for the symptomatology of
functional disorders [8]. However, the need to redefine the
concept of somatoform disorders in DSM-V is broadly felt,
and in this letter, we would like to suggest a contribution to
the discussion by focusing on reformulation of the concept of
somatoform disorder in DSM-V.
Several authors have suggested the whole category of
Somatoform disorders in DSM-V be scrapped. As an
alternative, these authors suggest either physical illness
with psychological factors be recorded on Axis I or
functional physical symptoms on Axis III [9]. Otherwise,
“physical symptom disorder” has been suggested by the
Conceptual Issues in Somatoform and Similar Disorders
Work Group to replace somatization disorder, undifferen-
tiated somatoform disorder, and pain disorder, as a
diagnostic category that should reside in Axis III [10,11].
Fava et al. [12], in line with the work of the DCPR, suggested
the term psychological factors affecting either identified or
feared medical conditions not otherwise specified, and in an
editorial in this Journal, an overview is given of the concept
of Somatic Symptom Disorders as envisioned by the DSM-V
workgroup [13]. Although these suggestions to remove the
category of somatoform disorders are very worthwhile, they
imply to replace them by another distinct category. We
would suggest taking this one step further, as follows.
Somatoform disorder is a negative diagnosis: it implies the
lack of evidence for somatic illness. It would be of great
clinical benefit if not a negative diagnosis but a positive
diagnosis could be made. Therefore, no distinct category for
the symptoms so far categorized as somatoform disorder
should exist as a separate category, and the clinician should be
challenged to classify the symptoms otherwise, positively,
with clues for treatment. Surely, eliminating somatoform
disorder from the classification system does not eliminate the
somatic presentation of a cosyndromal mood disorder or
anxiety disorder by patients, and this behavior should be
mentioned in a classification system if it is so overbearing that
it has a negative influence on diagnosis and treatment of the
cosyndromal disorder. Such behavioral and learned patterns
in the doctor-patient interaction, in which depressed patients
tend to present to doctors with physical symptoms, are very
important to guide us in the diagnostic procedures and
treatments that we follow for these patients. However, help-
seeking behavior is not necessarily a disorder, and the
concept of a depressive or anxiety disorder with somatic
presentation might protect primary care practitioners and
psychiatrists from non therapeutic behavior. Therefore, we
suggest that the essence of what is now commonly classified
as somatoform disorder should be the help seeking behavior
that focuses on the “wrong” medical specialist or treatment
setting. DSM-V should facilitate diagnosis and classification
of cosyndromal depressive or other disorders that come into
place as candidates for specific treatment as much as possible.
The help-seeking behavior, if it indeed disturbs treatment as
needed, should be introduced as a sub classification of the
diagnosed depressive or anxiety disorder, in the classification
of mood disorders and anxiety disorders in DSM-V. Somato-
form disorders as category can then be abolished and should
not be replaced by another distinct category. The differential
aspects between DSM-IV and the proposed classification in
DSM-V is shown in Table 1.
We suggest the concept of depressive disorders and an-
xiety disorders be expanded in DSM-V with the following
sub classifications that have clear implications for treatment:
(1) with pain, (2) with somatic presentation, or (3) with
hypochondriacal worries. In the minority of cases in which
criteria for another classification such as depressive or
anxiety disorder cannot be met, in which medical illness or
medical symptoms exists, but the illness behavior is a clear
disturbing factor in medical treatment, we suggest☆ The writing of this article was not supported by a research grant.
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classification as the V-code “medical symptoms or medical
illness with non compliance to treatment” in Axis I, with
mentioning of the symptoms in Axis III. In the case of
somatization disorder, we suggest classification as the
V-code “multisymptomatic medically unexplained symp-
toms with non-compliance to treatment” in Axis I, with
mentioning of the symptoms in Axis III. As can be seen,
somatization disorder is thus removed, conversion disorder
is moved to the dissociative disorders section, and body
dysmorphic disorder, to the Anxiety Disorders section; in
this letter, we focus on the comorbidity-related issues.
In summary, the decision to abolish the category of
somatoform disorders as such and to compel clinicians to
classify somatic symptom presentation as a behavioral
feature of cosyndromal depressive or anxiety disorder or as
noncompliance to treatment on Axis I is supported by a vast
body of research and would offer a positive criterion for
classification as well as clues for treatment that are badly
needed in the clinical management of these patients.
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The proposed diagnosis of somatic symptom disorders in
DSM-V to replace somatoform disorders in DSM-IV—A
preliminary report
Author's response to letters from Shröder and van der
Feltz-Cornelis
We are pleased that the authors of these letters appreciate
our efforts to be open regarding the proposed changes to the
diagnostic criteria of the Somatoform Disorders chapter of
DSM-IV [1,2]. It is gratifying also that they concur with
our impression that the DSM-IV chapter needs extensive
modification and they have made valuable contributions to
the debate regarding these criteria. We agree with the
suggestion in both letters that we should avoid the unhelpful
terms ‘somatoform’ and ‘medically unexplained.’
Schröder and Fink [1] comment on the three criteria that
have been proposed for the comprehensive diagnosis,
provisionally entitled “Complex Somatic Symptom Dis-
order.” With regard to the first criterion point, we note their
concern that the draft description, as provided in our article,
seemed to give undue emphasis to matters such as patients'
difficulty coping with, and tolerating, physical discomfort.
As a result of this and other feedback, we are likely to modify
this section. What we are striving for is a description of the
disorder that is precise and unambiguous.
We do respect the knowledge and experience of
clinicians treating patients with “severe and chronic
functional symptoms and somatization disorder,” but our
proposed definition must define a much broader group of
patients than this, including those seen frequently in
primary care. Population surveys are therefore relevant, but
we read the evidence differently from Schröder and Fink
[1]. We do not interpret existing evidence as indicating that
medically unexplained symptom clusters into gastrointest-
inal, cardiopulmonary, and musculoskeletal clusters “with
specific neurobiological disturbances underlying these
clusters.” Schröder and Fink [1] quote their own study in
this respect together with several others in Table 1, but
they omit three other important studies [3–5] all of which
found evidence for a single factor underlying a large
number of symptoms. Both the study of Deary [6] and a
systematic review concluded that the data do not provide
convincing support for a consistent picture of the
clustering of somatic symptoms [7]. We believe therefore
that it is premature to conclude that clusters of symptoms
with specific underlying neurobiological disturbances can
be used to build a diagnostic scheme. By proposing a
single, inclusive diagnosis of complex somatic symptoms,
we aim, in this section of DSM-V, to allow future research
to test whether particular patterns of symptoms are indeed
supported by epidemiological research and whether these
are found to have biological substrates. We guard against
making premature subdivisions which may limit the
usefulness of future research.
The same approach would prevent us from accepting the
evidence provided by Schröder and Fink [1] that health
anxiety should be defined as a separate category from that
primarily representing numerous bodily symptoms. We
regard this as a premature conclusion as, once again, the
evidence of overlap between numerous bodily symptoms
and health anxiety is very considerable, up to 60% according
to one study [7] and nearly 50% in Fink's own study [8].
With regard to our third criterion, increased pattern of
health care use, Schröder and Fink [1] reject this as a basis
for making a diagnosis. In their view, the “evidence is
‘unequivocal’ that the Health System as a whole and the
doctor/patient consultation in particular assume an important
role in the initiation and maintenance of so called medically
unexplained symptoms.” They think therefore that it is
wrong to blame the patient for what they regard as
shortcomings in the health care system and doctor's lack
of communication skills. The workgroup accepts the
evidence that there are difficulties in some doctor–patient
encounters for the patients in this group and we have been
exploring ways of operationalizing the unsatisfactory nature
of the utilization.
In their letter, van der Feltz-Cornelis and van Balkom [2]
support the suggestion, previously made by Mayou et al. [9],
that the whole category of somatoform disorders be
scrapped. They suggest (a) that the majority of patients
previously diagnosed as “somatoform disorder” could be
encompassed in the diagnoses of depressive or anxiety
disorder and (b) that these latter diagnoses could be enhanced
by subcategories indicating that the depression or anxiety is
accompanied by pain, somatic presentations, or hypochon-
driacal worries.
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